• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Early-life program significantly improves infant weight status at 12 months

byMolly MunsellandAlex Gipsman, MD
August 1, 2021
in Chronic Disease, Endocrinology, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A program that implemented behavioral and community-level interventions at community health centers, beginning in early pregnancy, significantly decreased the percentage of infants overweight at 6 and 12 months compared to infants at control sites.

2. The size of the program’s effect on children’s weight outcomes decreased between 6 and 12 months.

Evidence Rating Level: 2 (Good)

Study Rundown: The prevalence of childhood obesity has continued to rise at an alarming pace in recent years. Few studies have examined the impact of early-life interventions on the development of childhood obesity, despite evidence suggesting that the period from birth to two years may have an important role in childhood weight. The First 1000 Days program implements systems-level interventions at 2 community health centers for women starting in early pregnancy and continues until the infant is 2 years old. It includes provider training, increased weight tracking, patient education, assistance with navigating government resources, and individualized coaching. This study examined outcomes of the program up until the infant’s first year of life. Relative to women and infants receiving standard care, those in the program had lower weight-for-length and lower odds of being overweight at 6 months and 12 months of age. The magnitude of these differences was smaller at 12 months than at 6 months. The study program was innovative in enrolling mothers early in pregnancy and in incorporating public health services as well as training and involving providers across several disciplines. However, the many-pronged approach of this program design might make replication in other healthcare settings challenging. Additionally, lack of randomization places the study at high risk of selection bias, with more motivated families potentially enrolling in the program. The duration of the program effect on weight outcomes at 2 years of age and throughout childhood is unknown at this time.

Click to read the study in Pediatrics

Relevant Reading: From conception to infancy — early risk factors for childhood obesity

RELATED REPORTS

#VisualAbstract: Tirzepatide Superior to Semaglutide in Obese Adults Without Diabetes

Eli Lilly Takes Legal Action Against Telehealth Startups

Increased tirzepatide use for glycemic and weight control since United States market entry

In-Depth [prospective cohort]: This quasi-experimental study did not randomize or blind patients to the study interventions. Mothers were enrolled in the First 1000 Days program during the first trimester of pregnancy and received program interventions throughout pregnancy and until their children were 2 years old. The intervention and comparison health centers, all in the Boston area, serve patients who are disproportionately low-income and Hispanic. Data from birth to age 15 months was collected using the electronic health record. In a model adjusted for between-site differences in infant race and ethnicity, public insurance status, and birth weight, infants enrolled in the program had an average weight-for-length z score -0.27 lower than the control group at 6 months and -0.18 lower at 12 months. The odds of being overweight, defined as weight-for-length > 97.7th percentile, at 6 months in the intervention versus control group were 0.46 (95% CI 0.28 to 0.76), but increased to 0.60 (CI 0.39 to 0.92) at 12 months. Mothers at program sites were more likely to complete a postpartum visit than those at control sites, but no significant effect on postpartum weight retention was observed.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: childhood obesitycommunity healthobesity
Previous Post

#VisualAbstract Patients with follicular lymphoma experience a plateau in therapy initiation rates during their first decade of observation after diagnosis

Next Post

Pediatric physicians have lower lifetime earning potential than adult physicians

RelatedReports

#VisualAbstract: Tirzepatide Superior to Semaglutide in Obese Adults Without Diabetes
StudyGraphics

#VisualAbstract: Tirzepatide Superior to Semaglutide in Obese Adults Without Diabetes

May 20, 2025
Food environment associated with gestational diabetes
Pharma

Eli Lilly Takes Legal Action Against Telehealth Startups

May 15, 2025
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Increased tirzepatide use for glycemic and weight control since United States market entry

April 14, 2025
Provision of medically-tailored meals linked with lower admissions and medical spending
Chronic Disease

4:3 intermittent fasting effective for weight loss among adults with obesity

April 2, 2025
Next Post
Nonmedical expenses of pediatric hospitalizations have disproportionate effects

Pediatric physicians have lower lifetime earning potential than adult physicians

Previous concussion linked to prolonged symptoms following second concussion

Hereditary hemochromatosis risk genotypes may improve endurance performance in male athletes

Patient Basics: Colonoscopy

Video capsule endoscopy is safe and effective in the initial evaluation of acute gastrointestinal bleeding during the COVID-19 pandemic

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis
  • Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer
  • Dapagliflozin may improve outcomes in patients with metabolic dysfunction-associated steatohepatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.